Catheter Ablation for Atrial Fibrillation

Albert, Christine M.; Bhatt, Deepak L.

doi:10.1001/jama.2018.17478

Cited by 11 publications

(8 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There were also clinically important and significant improvements in QoL at 12 months in symptomatic patients 5 . There was also a signal for decreased cardiovascular hospitalizations, although not centrally adjudicated, and there may be a signal for mortality benefit of catheter ablation in the subgroup of patients with systolic dysfunction 6 …”

mentioning

confidence: 92%

See 1 more Smart Citation

Surgical ablation for atrial fibrillation: Breaking the bank or worth every penny?

Lambrakos

Goldberger

2020

J Card Surg

View full text Add to dashboard Cite

mentioning

confidence: 92%

“…5 There was also a signal for decreased cardiovascular hospitalizations, although not centrally adjudicated, and there may be a signal for mortality benefit of catheter ablation in the subgroup of patients with systolic dysfunction. 6 The on-treatment analysis showed even more significant benefits, even with mortality reduction.…”

mentioning

confidence: 97%

Surgical ablation for atrial fibrillation: Breaking the bank or worth every penny?

Lambrakos

Goldberger

2020

J Card Surg

View full text Add to dashboard Cite

“…There were also clinically important and significant improvements in quality of life (QOL) at 12 months in symptomatic patients (5). There was also a signal for decreased cardiovascular hospitalizations, although not centrally adjudicated, and there may be a signal for mortality benefit of catheter ablation in the subgroup of patients with systolic dysfunction (6). On-treatment analysis showed even more significant benefits, even with mortality reduction.…”

mentioning

confidence: 99%

Surgical Ablation for Atrial Fibrillation: Breaking the bank or worth every penny?

Lambrakos

Goldberger

2020

Preprint

View full text Add to dashboard Cite

Chow et al (1) report that significant financial resources are spent on surgical AF ablation in Canada with unclear long-term benefits and "scientifically rigorous" data regarding reduction in mortality and stroke risks. The authors call for large prospective studies examining clinically important outcomes to justify the routine use of concomitant surgical AF ablation (SA) and to guide allocation of healthcare funds. Based on their analysis, they assert that concomitant surgical AF ablation during cardiac surgery should be reconsidered. To better put these findings into context, it is important to examine the assumptions made and data utilized to assess both cost and benefit.

show abstract

“…It increases the risk of stroke fivefold and doubles the risk of death 1. Although it is often asymptomatic, symptoms may include palpitations, breathlessness, dizziness, and exercise intolerance and lead to a reduced quality of life 2…”

mentioning

confidence: 99%